4//SEC Filing
Noble James 4
Accession 0001104659-20-042013
CIK 0001621227other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:06 PM ET
Size
5.4 KB
Accession
0001104659-20-042013
Insider Transaction Report
Form 4
Noble James
DirectorChief Executive Officer
Transactions
- Award
Option to purchase Ordinary Shares
2020-04-01+31,000→ 31,000 totalExercise: $0.45From: 2021-04-01Exp: 2030-04-01→ Ordinary Shares (31,000 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.36 based on an exchange rate of $U.S. 1.245481 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001388000
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:06 PM ET
- Size
- 5.4 KB